Role of TGF-β in oncogenesis
✍ Scribed by Michael Weller; W. Wick; M. Platten
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 24 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
✦ Synopsis
Role of TGF- in Oncogenesis
Transforming growth factor- (TGF-) is the founding member of a large and growing family of growth factors with regulatory properties of a multitude of cellular processes including cell proliferation, differentiation, motility, adhesion, and death. Given this multifunctional nature of TGF-, it is not surprising that during the past two decades researchers have discovered that TGF- is an important factor involved in the genesis of cancers of various origin. This special issue is dedicated to the emerging role of TGF- in oncogenesis.
The function of TGF- in cancer biology is rather complex since it appears that TGF- acts as a growth inhibitor in the early stages of tumorigenesis but may promote tumor growth at later stages. This is not unexpected, keeping in mind that TGF- acts on virtually every cell type in the body and that tumor growth is a result of a complex tumor-host-interaction. Thus, specificity of signaling can only be achieved by complex processing and signaling events.
Hence, the first review by K. Koli et al. focusses on the cellular and extracellular mechanisms underlying the processing of active TGF- from latent complexes. These mechanisms are under tight control of extracellular matrix (ECM) proteins. Disturbances of these control mechanisms may well contribute to tumor development.
The review by J.N. Rich et al. focusses on the signal transduction pathways initiated by TGF-. Signal transduction through TGF- relies on the coordinate assembly of TGF- receptors and distinct activation patterns of downstream transcription factors, the Smad proteins. Again, the complexity of these pathways reflects the ability of TGF- to modulate a variety of cellular functions, and disruption of distinct signaling components may promote tumor development. Coordinated cell proliferation, differentiation, motility, and death are critical for the development of all organisms. The same mechanisms involved in development often contribute to carcinogenesis. Knock-out studies have revealed a central role for TGF- in mouse development. The review by C.L. Mummery elucidates the role of TGF- in mouse development.
Immune surveillance is important for every organism to control tumor development. During malignant progression, tumors may escape host immunity. This immune-escape may be attributed to factors released by tumor cells, including TGF-. The review by C. Beck et al. analyzes various effects of TGF- on immune surveillance of tumor cells.
There are some organs with constitutively low immune surveillance, including the brain and the eye. Maintainance of this immune privilege has in part been attributed to the action of TGF-. It is tempting to speculate that the microenvironment in these immuneprivileged sites may predispose to tumor development.
📜 SIMILAR VOLUMES
Systemic sclerosis (SSc) is a multisystem connective tissue disorder in which there is progressive fibrosis. Transforming growth factor beta (TGF ) has wide-ranging cellular actions. It is a potent chemoattractant for human dermal fibroblasts, from which it may induce synthesis of collagen, which su
## Abstract Activating Transcription Factor‐2 is a sequence‐specific DNA‐binding protein that belongs to the bZIP family of proteins and plays diverse roles in the mammalian cells. In response to stress stimuli, it activates a variety of gene targets including __cyclin A, cyclin D__ and __c‐jun__,
The mouse skin model of chemical carcinogenesis has been very well characterized with respect to epigenetic changes, which occur during tumour cell initiation, promotion and progression. The use of transgenic and gene knock-out mice has contributed greatly to knowledge in this area. The H-ras geneti
Retinoic acid (RA) plays an important role in embryogenesis, by regulating morphogenesis, cell proliferation, differentiation, and extracellular matrix production. RA exposure on gestational day (GD) 12 in CD-1 mice results in delayed palatal shelf elevation and subsequent clefts in the secondary pa